Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 5Phase 1/2 3Phase 1 3Phase 2/3 1

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Non-Small-Cell Lung 45Neoplasms 26Colorectal Neoplasms 24Neoplasm Metastasis 22Recurrence 21Ovarian Neoplasms 21Pancreatic Neoplasms 20Breast Neoplasms 19Squamous Cell Carcinoma of Head and Neck 17Melanoma 16Glioblastoma 15Prostatic Neoplasms 14Lymphoma, Large B-Cell, Diffuse 13Endometrial Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Multiple Myeloma 12Lymphoma, Non-Hodgkin 12Triple Negative Breast Neoplasms 11Lung Neoplasms 11Glioma 10Colonic Neoplasms 10Carcinoma, Renal Cell 10Stomach Neoplasms 9Rectal Neoplasms 9Gastrointestinal Neoplasms 9Lymphoma, Follicular 8Lymphoma 8Leukemia, Myeloid, Acute 8Head and Neck Neoplasms 8Brain Neoplasms 8

Interventions

Ipilimumab 1Cell- and Tissue-Based Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Liver Neoplasms × 30 days × Clear all
NCT07227012 2026-06-04

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Pfizer

Phase 1/2 Recruiting
138 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06084884 2026-05-22

ATHENA

AstraZeneca

Phase 1/2 Active not recruiting
94 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07587034 2026-05-20

HAIC-TACE Plus Apatinib and Camrelizumab for Liver Cancer

Shanghai Zhongshan Hospital

Phase 1/2 Not yet recruiting
315 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡